Related Experiment Video
Updated: Jul 2, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses
1Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. AVCCtracker@intmedpress.com
Abstract:
Although most of the recent attempts to develop new antiviral agents have been focussed on RNA viruses (in particular, HIV and hepatitis C virus), a few new compounds are now awaiting their entry into the field of DNA viruses, particularly poxviruses, such as variola virus, because of the bioterrorist context, and herpesviruses, such as herpes simplex virus and cytomegalovirus, where the market scene has for many years been dominated by acyclovir, penciclovir and ganciclovir and their respective orally bioavailable prodrugs: valaciclovir, famciclovir and valganciclovir. Here, we review the current 'state of the art' with old compounds ready to rotate off and new compounds eagerly awaiting to appear on the continuously evolving scene of antiviral drug development.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Subviral Agents
Size and Structure of Viral Genomes
Retrovirus Life Cycles
Viruses with RNA Genomes

